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Background: Although there are reports of late neointimal proliferation following drug eluting stent implantation, with discussion of differences 
according to the type of stent used, there is hardly any mention of differences in neointimal proliferation according to lesion characteristics or 
clinical characteristics.
Method: Subjects were 72 patients, 82 lesions, who underwent follow-up angiography at 6 months and 12 months after sirolimus-eluting stent 
(SES) implantation.
Late loss up to 6 months after SES implantation(early late loss) and late loss from 6 months after SES implantation to up to 12 months(late loss 
at late phase) from quantitative coronary analysis data were comparatively studied according to differences in clinical and lesion characteristics.
Calcification of aortic valve was defined by echocardiography, calcification of thoracic aorta was defined by chest x-rays and calcification of coronary 
artery was defined by angiography.
Results: Late loss at 6 months after SES implantation was 0.31±0.52 mm and late loss from 6 months to 12 months was 0.24±0.57 mm. Results 
are as shown in the following table. 
Conclusion: Neointimal proliferation was prone to occur early after Sirolimus-Eluting Stent implantation in calcification of the coronary artery, 
thoracic aorta, or aortic valve, and late neointimal proliferation was prone to occur in stent fracture. Bifurcated lesions or eldery patients had hardly 
no neointimal proliferation in the late stage.
Difference of Late Loss According to Clinical and Lesion Characteristics
Calcification of 
the aortic valve 
(n=23)
No 
calcification 
of the aortic 
valve(n=57)
p value
Calcification 
of the thoracic 
aorta(n=23)
No 
calcification 
of the thoracic 
aorta(n=59)
p value
Calcification of 
coronary artery 
(n=37)
No 
calcification of 
coronary artery 
(n=45)
p value
Late loss(0-
6months)
0.62±0.48 0.17±0.50 <0.01 0.49±0.49 0.24±0.54 0.05 0.42±0.50 0.21±0.55 0.07
Late loss(6-
12months)
0.29±0.65 0.13±0.40 n.s. 0.29±0.69 0.12±0.36 n.s. 0.17±0.54 0.18±0.39 n.s.
Stent 
fracture(n=7)
No stent 
fracture(n=75)
p value
Age ≥75 years 
old(n=18)
Age <75 years 
old(n=64)
p value
Bifurcated 
lesion(n=14)
No bifurcated 
lesion(n=68)
p value
Late loss(0-
6months)
0.11±0.32 0.32±0.52 n.s. 0.45±0.52 0.27±0.51 n.s. 0.35±0.42 0.27±0.61 n.s.
Late loss(6-
12months)
0.94±0.85 0.11±0.34 <0.01 0.04±0.45 0.35±0.68 <0.05 0.002±0.29 0.32±0.52 <0.05
